CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 143 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $3,198,713 | +475.8% | 192,926 | +546.0% | 0.02% | +466.7% |
| Q4 2022 | $555,508 | -58.0% | 29,866 | -71.0% | 0.00% | -66.7% |
| Q3 2022 | $1,322,000 | +551.2% | 103,008 | +321.6% | 0.01% | +800.0% |
| Q1 2022 | $203,000 | -17.5% | 24,431 | -32.6% | 0.00% | 0.0% |
| Q4 2021 | $246,000 | +30.2% | 36,271 | -26.1% | 0.00% | -50.0% |
| Q1 2020 | $189,000 | +243.6% | 49,050 | +242.2% | 0.00% | – |
| Q2 2019 | $55,000 | -21.4% | 14,332 | -60.9% | 0.00% | – |
| Q4 2018 | $70,000 | -40.2% | 36,700 | +18.3% | 0.00% | -100.0% |
| Q3 2018 | $117,000 | +50.0% | 31,012 | +24.0% | 0.00% | – |
| Q2 2018 | $78,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 17,875,655 | $94,920,000 | 9.39% |
| TANAKA CAPITAL MANAGEMENT INC | 283,334 | $1,505,000 | 4.86% |
| GABLES CAPITAL MANAGEMENT INC. | 490,564 | $2,606,000 | 1.84% |
| MANGROVE PARTNERS IM, LLC | 2,508,838 | $13,322,000 | 1.61% |
| Broadfin Capital, LLC | 880,303 | $4,674,000 | 0.86% |
| Atom Investors LP | 1,012,355 | $5,376,000 | 0.37% |
| Capital Impact Advisors, LLC | 179,868 | $948,000 | 0.36% |
| KNOTT DAVID M | 151,415 | $804,000 | 0.34% |
| EMERALD ADVISERS, LLC | 1,175,958 | $6,244,000 | 0.29% |
| CADENCE CAPITAL MANAGEMENT LLC | 371,075 | $1,970,000 | 0.28% |